#5 - Centrus Energy (NYSE:LEU)
Centrus Energy Corp. (NYSE: LEU) is a global supplier of nuclear fuel components and services. One of the company’s core business units deals with low-enriched uranium. The ADVANCE Act, recently passed by Congress, “authorizes significant investments to bolster the domestic uranium enrichment capacity.”
This includes high-assay low-enriched uranium (HALEU), which is essential for advanced nuclear reactors and is likely to become the new standard. Centrus is the only U.S. company licensed to make HALEU, which it has been producing in small quantities.
Now may be an ideal time for investors to take a close look at Centrus. LEU stock is down over 23% this year as its recent quarterly earnings reflected the supply-demand imbalance with uranium. However, analysts believe this imbalance is temporary and have a $67 consensus price target, which is 67% higher than the LEU stock price as of July 8, 2024.
About Centrus Energy
Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.
Read More - Current Price
- $64.43
- Consensus Rating
- Buy
- Ratings Breakdown
- 2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $63.50 (1.4% Downside)
